Donor-specific antibodies accelerate arteriosclerosis after kidney transplantation

Journal of the American Society of Nephrology

Volumn 22, Issue 5, 2011, Pages 975-983

  Hill, Gary S ^a   Nochy, Dominique ^a,b   Bruneval, Patrick ^a,b   Van Huyen, J P Duong ^a,b   Glotz, Denis ^c   Suberbielle, Caroline ^c   Zuber, Julien ^b,d   Anglicheau, Dany ^b,d   Empana, Jean Philippe ^e   Legendre, Christophe ^b,d   Loupy, Alexandre ^b,d,e  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DONOR SPECIFIC ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTERIOSCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MORPHOLOGY; PRIORITY JOURNAL; VASCULITIS;

EID: 79955599550     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010070777     Document Type: Article

References (25)

1. Colvin RB: Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 18: 1046-1056, 2007
2. Colvin RB: Renal transplant pathology. In: Heptinstall's Pathology of the Kidney, 6th ed., edited by Jennette JC, Olson JL, Schwartz MM, Silva FG, Philadelphia, Lippincott, Williams & Wilkins, 2007, pp 1347- 1490
3. Cornell LD, Smith RN, Colvin RB: Kidney transplantation: Mechanisms of rejection and acceptance. Annu Rev Pathol 3: 189-220, 2008 (Pubitemid 351488280)
4. Racusen LC, Colvin RB, Solez K, Mihatsch MJ, Halloran PF, Campbell PM, Cecka MJ, Cosyns JP, Demetris AJ, Fishbein MC, Fogo A, Furness P, Gibson IW, Glotz D, Hayry P, Hunsickern L, Kashgarian M, Kerman R, Magil AJ, Montgomery R, Morozumi K, Nickeleit V, Randhawa P, Regele H, Seron D, Seshan S, Sund S, Trpkov K: Antibody-mediated rejection criteria: An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 3: 708-714, 2003 (Pubitemid 36745243)
5. Lefaucheur C, Nochy D, Hill GS, Glotz: Are transplant endarteritis (v1, v2) part of the spectrum of antibody-mediated rejection? [Abstract] 9th Banff Conference on Allograft Pathology, La Coruña, Spain, 2007
6. Shimizu T, Ishida H, Shirakawa H, Omoto K, Tsunoyama K, Tokumoto T, Tanabe K: Clinicopathological analysis of acute vascular rejection cases after renal transplantation. Clin Transplant 24[Suppl 22]: 22-26, 2010
7. Sis B, Mengel M, Eineke L, Hidalgo J FPHP: Microarray analysis of isolated v-lesion in kidney transplant biopsies for cause. [Abstract] American Transplant Congress, San Diego, 2010
8. Haas M, Montgomery RA, Segev DL, Rahman MH, Racusen LC, Bagnasco SM, Simpkins CE, Warren DS, Lepley D, Zachary AA, Kraus ES: Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts. Am J Transplant 7: 576-585, 2007 (Pubitemid 46376440)
9. Gloor JM, Cosio FG, Rea DJ, Wadei HM, Winters JL, Moore SB, Degoey SR, Lager DJ, Grande JP, Stegall MD: Histologic findings one year after positive crossmatch or ABO blood group incompatible living donor kidney transplantation. Am J Transplant 6: 1841-1847, 2006
10. Bian H, Reed EF: Anti-HLA class I antibodies transduce signals in endothelial cells resulting in FGF receptor translocation, down-regulation of ICAM-1 and cell proliferation. Transplant Proc 33: 311, 2001 (Pubitemid 32237389)
11. Bian H, Reed EF: Alloantibody-mediated class I signal transduction in endothelial cells and smooth muscle cells: Enhancement by IFNgamma and TNF-alpha. J Immunol 163: 1010-1018, 1999 (Pubitemid 29328114)
12. Bieri M, Oroszlan M, Farkas A, Ligeti N, Bieri J, Mohacsi P: Anti-HLA I antibodies induce VEGF production by endothelial cells, which increases proliferation and paracellular permeability. Int J Biochem Cell Biol 41: 2422-2430, 2009
13. Hill GS, Nochy D, Loupy A: Accelerated arteriosclerosis: A form of transplant arteriopathy. Curr Opin Organ Transplant 15: 11-15, 2010
14. Loupy A, Suberbielle-Boissel C, Zuber J, Anglicheau D, Timsit MO, Martinez F, Thervet E, Bruneval P, Charron D, Hill GS, Nochy D, Legendre C: Combined posttransplant prophylactic IVIg/anti-CD 20/ plasmapheresis in kidney recipients with preformed donor-specific antibodies: A pilot study. Transplantation 89: 1403-1410, 2010
15. Le Bas-Bernardet S, Hourmant M, Valentin N, Paitier C, Giral-Classe M, Curry S, Follea G, Soulillou JP, Bignon JD: Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. Transplantation 75: 477-482, 2003 (Pubitemid 36241142)
16. Campos EF, Tedesco-Silva H, Machado PG, Franco M, Medina- Pestana JO, Gerbase-DeLima M: Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure. Am J Transplant 6: 2316-2320, 2006 (Pubitemid 44359416)
17. Issa N, Cosio FG, Gloor JM, Sethi S, Dean PG, Moore SB, DeGoey S, Stegall MD: Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation 86: 681-685, 2008
18. Sumitran-Holgersson S: Relevance of MICA and other non-HLA antibodies in clinical transplantation. Curr Opin Immunol 20: 607-613, 2008
19. Stastny P, Zou Y, Fan Y, Qin Z, Lavingia B: The emerging issue of MICA antibodies: Antibodies to MICA and other antigens of endothelial cells. Contrib Nephrol 162: 99-106, 2009
20. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723, 1999 (Pubitemid 29082898)
21. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, Halloran PF, Baldwin W, Banfi G, Collins AB, Cosio F, David DS, Drachenberg C, Einecke G, Fogo AB, Gibson IW, Glotz D, Iskandar SS, Kraus E, Lerut E, Mannon RB, Mihatsch M, Nankivell BJ, Nickeleit V, Papadimitriou JC, Randhawa P, Regele H, Renaudin K, Roberts I, Seron D, Smith RN, Valente M: Banff 07 classification of renal allograft patholoy: Updates and future directions. Am J Transplant 8: 753-760, 2008 (Pubitemid 351347767)
22. Lefaucheur C, Nochy D, Hill GS, Suberbielle-Boissel C, Antoine C, Charron D, Glotz D: Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 7: 832-841, 2007 (Pubitemid 46481179)
23. Lefaucheur C, Nochy D, Andrade J, Verine J, Gautreau C, Charron D, Hill GS, Glotz D, Suberbielle-Boissel C: Comparison of combination Plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection. Am J Transplant 9: 1099-1107, 2009
24. Lefaucheur C, Suberbielle-Boissel C, Hill GS, Nochy D, Andrade J, Antoine C, Gautreau C, Charron D, Glotz D: Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant 8: 324-331, 2008
25. Loupy A, Suberbielle-Boissel C, Hill GS, Lefaucheur C, Anglicheau D, Zuber J, Martinez F, Thervet E, Mejean A, Charron D, van Huyen JP, Bruneval P, Legendre C, Nochy D: Outcome of subclinical antibodymediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 9: 2561-2570, 2009